Innate immunity to Mycobacterium tuberculosis

Clinical Microbiology Reviews

Volumn 15, Issue 2, 2002, Pages 294-309

  Van Crevel, Reinout ^a   Ottenhoff, Tom H M ^a   Van der Meer, Jos W M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 4; INTERLEUKIN 6; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANTIGEN PRESENTATION; ANTIGEN RECOGNITION; CYTOKINE PRODUCTION; HOST RESISTANCE; HUMAN; IMMUNOREACTIVITY; IMMUNOREGULATION; INFECTION RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; REVIEW; T LYMPHOCYTE; TUBERCULOSIS;

CYTOKINES; HUMANS; IMMUNITY, NATURAL; MYCOBACTERIUM TUBERCULOSIS; PHAGOCYTOSIS; TUBERCULOSIS;

ACTINOBACTERIA (CLASS); MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS; UNCULTURED ACTINOMYCETE;

EID: 0036222899     PISSN: 08938512     EISSN: None     Source Type: Journal    
DOI: 10.1128/CMR.15.2.294-309.2002     Document Type: Review

References (260)

1. Functional diversity of helper T lymphocytes
2. Mechanisms of phagocytosis in macrophages
3. Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
4. Interleukin-12 receptor beta1 deficiency in a patient with abdominal tuberculosis
5. Inherited interleukin 12 deficiency in a child with bacille Calmette-Guerin and Salmonella enteritidis disseminated infection
6. Host responses and antigens involved in protective immunity to Mycobacterium tuberculosis
7. In vitro effects of interleukin-4 on interferon-gamma-induced macrophage activation
8. s macrophages correlates with nitric oxide production
9. Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli. Reversal of the usual nonfusion pattern and observations on bacterial survival
10. The mannose receptor mediates uptake of pathogenic and nonpathogenic mycobacteria and bypasses bactericidal responses in human macrophages
11. Pathogenic Mycobacterium tuberculosis evades apoptosis of host macrophages by release of TNF-R2, resulting in inactivation of TNF-alpha
12. Natural immunity: A T-cell-independent pathway of macrophage activation, defined in the scid mouse
13. Patterns of cytokine production by mycobacterium-reactive human T-cell clones
14. Cytokine production at the site of disease in human tuberculosis
15. Structural deficiencies in granuloma formation in TNF gene-targeted mice underlie the heightened susceptibility to aerosol Mycobacterium tuberculosis infection, which is not compensated for by lymphotoxin
16. Selective increase in plasma tumor necrosis factor-alpha and concomitant clinical deterioration after initiating therapy in patients with severe tuberculosis
17. Immunopathologic effects of tumor necrosis factor alpha in murine mycobacterial infection are dose dependent
18. Tuberculosis and chronic hepatitis B virus infection in Africans and variation in the vitamin D receptor gene
19. Variations in the NRAMP1 gene and susceptibility to tuberculosis in West Africans
20. A conserved signaling pathway: The Drosophila toll-dorsal pathway
21. Cytokine patterns in tuberculous and sarcoid granulomas: Correlations with histopathologic features of the granulomatous response
22. Mycobacterium tuberculosis invades and replicates within type II alveolar cells
23. Dichotomy of cytokine profiles in patients and high-risk healthy subjects exposed to tuberculosis
24. Immunogenetics of leishmanial and mycobacterial infections: The Belem Family Study
25. Understanding the multiple functions of Nramp1
26. Impaired monocyte migration and reduced type 1 (Th1) cytokine responses in C-C chemokine receptor 2 knock-out mice
27. Association of tuberculosis and M tuberculosis-specific antibody levels with HLA
28. IL-10-producing T cells suppress immune responses in anergic tuberculosis patients
29. Host defense mechanisms triggered by microbial lipoproteins through toll-like receptors
30. Capacity of human neutrophils to kill Mycobacterium tuberculosis
31. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: Role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling
32. Roles of soluble fibronectin and beta 1 integrin receptors in the binding of Mycobacterium leprae to nasal epithelial cells
33. Cytokine levels correlate with a radiologic score in active pulmonary tuberculosis
34. Allelic association between the NRAMP1 gene and susceptibility to tuberculosis in Guinea-Conakry
35. Lipoarabinomannan, a possible virulence factor involved in persistence of Mycobacterium tuberculosis within macrophages
36. Killing of virulent Mycobacterium tuberculosis by reactive nitrogen intermediates produced by activated murine macrophages
37. Differential expression and cross-regulatory function of RANTES during mycobacterial (type 1) and schistosomal (type 2) antigen-elicited granulomatous inflammation
38. Antimicrobial activity of MHC class I-restricted CD8+ T cells in human tuberculosis
39. Characterization of the Mycobacterium tuberculosis phagosome and evidence that phagosomal maturation is inhibited
40. Efficacy of BCG vaccine in the prevention of tuberculosis. Meta-analysis of the published literature
41. Local immune responses correlate with presentation and outcome in tuberculosis
42. Stimulation of human gamma delta T cells by nonpeptidic mycobacterial ligands
43. Expression of memory immunity in the lung following re-exposure to Mycobacterium tuberculosis
44. Disseminated tuberculosis in interferon gamma genedisrupted mice
45. Interleukin 12 (IL-12) is crucial to the development of protective immunity in mice intravenously infected with mycobacterium tuberculosis
46. phox-/- mice
47. Relative permissiveness of macrophages from black and white people for virulent tubercle bacilli
48. Nonopsonic binding of Mycobacterium tuberculosis to complement receptor type 3 is mediated by capsular polysaccharides and is strain dependent
49. Selective induction of transforming growth factor beta in human monocytes by lipoarabinomannan of Mycobacterium tuberculosis
50. Pathogenesis of pulmonary tuberculosis: An interplay between tissue-damaging and macrophage-activating immune responses: Dual mechanisms that control bacillary multiplication
51. CR1, the C3b receptor, mediates binding of infective Leishmania major metacyclic promastigotes to human macrophages
52. Serum concentrations of vitamin D metabolites in untreated tuberculosis
53. Severe mycobacterial and Salmonella infections in interleukin-12 receptor-deficient patients
54. Mycobacteria-reactive Lyt-2+ T cell lines
55. Killing of Mycobacterium tuberculosis within human monocytes: Activation by cytokines and calcitriol
56. Effects of interleukin 4 on monocyte functions: Comparison to interleukin 13
57. Biologic basis for interleukin-1 in disease
58. Overview of interleukin-18: More than an interferon-gamma inducing factor
59. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: Relationship with the severity of pulmonary involvement
60. Induction and regulation of IL-15 expression in murine macrophages
61. Mutation in the signal-transducing chain of the interferon-gamma receptor and susceptibility to mycobacterial infection
62. Surfactant protein a promotes attachment of Mycobacterium tuberculosis to alveolar macrophages during infection with human immunodeficiency virus
63. An anti-inflammatory role for gamma delta T lymphocytes in acquired immunity to Mycobacterium tuberculosis
64. Assignment of the human macrophage mannose receptor gene (MRC1) to 10p13 by in situ hybridization and PCR-based somatic cell hybrid mapping
65. Presence or absence of TGF-beta determines IL-4-induced generation of type 1 or type 2 CD8 T cell subsets
66. IL-4, IL-5 and IL-10 are not required for the control of M. bovis-BCG infection in mice
67. Macrophage receptors for Mycobacterium tuberculosis
68. LPS-binding proteins and receptors
69. Surfactant protein D binds to Mycobacterium tuberculosis bacilli and lipoarabinomannan via carbohydrate-lectin interactions resulting in reduced phagocytosis of the bacteria by macrophages
70. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
71. Tumor necrosis factor-alpha is required in the protective immune response against Mycobacterium tuberculosis in mice
72. Inhibition of ex vivo proinflammatory cytokine secretion in fatal Mycobacterium tuberculosis infection
73. Defective monocyte costimulation for IFN-gamma production in familial disseminated Mycobacterium avium complex infection: Abnormal IL-12 regulation
74. Regulation of interleukin-12 by interleukin-10, transforming growth factor-beta, tumor necrosis factor-alpha, and interferon-gamma in human monocytes infected with Mycobacterium tuberculosis H37Ra
75. Interleukin-12 production by human monocytes infected with Mycobacterium tuberculosis: Role of phagocytosis
76. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection
77. Mannan-binding lectin in the sub-Saharan HIV and tuberculosis epidemics
78. Pulmonary surfactant protein A mediates enhanced phagocytosis of Mycobacterium tuberculosis by a direct interaction with human macrophages
79. + T cells in HLA-transgenic mice and humans
80. Defective antigen presentation by Mycobacterium tuberculosis-infected monocytes
81. + T cell clones producing both interferon-gamma and interleukin-10 predominate in bronchoalveolar lavages of active pulmonary tuberculosis patients
82. Association of an HLA-DQ allele with clinical tuberculosis
83. Interleukin-10 downregulates Mycobacterium tuberculosis-induced Th1 responses and CTLA-4 expression
84. A study of vitamin D levels in Indonesian patients with untreated pulmonary tuberculosis
85. Kinetics of accumulation of gamma delta receptor-bearing T lymphocytes in mice infected with live mycobacteria
86. Host resistance to intracellular infection: Mutation of natural resistance-associated macrophage protein 1 (Nramp1) impairs phagosomal acidification
87. Cutting edge: Functional interactions between toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin
88. A Toll-like receptor recognizes bacterial DNA
89. Activation of human dendritic cells following infection with Mycobacterium tuberculosis
90. Correlation between the kinetics of TH1/Yh2 cells and pathology in a murine model of experimental pulmonary tuberculosis
91. The role of TNF-alpha in T-cell-mediated inflammation depends on the Th1/Th2 cytokine balance
92. In vitro restoration of T cell responses in tuberculosis and augmentation of monocyte effector function against Mycobacterium tuberculosis by natural inhibitors of transforming growth factor beta
93. Complement receptor-mediated uptake and tumor necrosis factor-alpha-mediated growth inhibition of Mycobacterium tuberculosis by human alveolar macrophages
94. Augmentation of apoptosis and interferon-gamma production at sites of active Mycobacterium tuberculosis infection in human tuberculosis
95. Depressed T-cell interferon-gamma responses in pulmonary tuberculosis: Analysis of underlying mechanisms and modulation with therapy
96. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis
97. Compartmentalization of pro-inflammatory cytokines in tuberculous pleurisy
98. Abnormal regulation of interferon-gamma, interleukin-12, and tumor necrosis factor-alpha in human interferon-gamma receptor 1 deficiency
99. Reactivation of tuberculosis is associated with a shift from type 1 to type 2 cytokines
100. Dynamics of plasma cytokine levels in patients with advanced HIV infection and active tuberculosis: Implications for early recognition of patients with poor response to anti-tuberculosis treatment
101. Oligodeoxynucleotides containing palindrome sequences with internal 5′-CpG-3′ act directly on human NK and activated T cells to induce IFN-gamma production in vitro
102. Activation of gamma delta T cells in the primary immune response to Mycobacterium tuberculosis
103. Cytokine gene expression by cultures of human lymphocytes with autologous Mycobacterium tuberculosis-infected monocytes
104. Killing of Mycobacterium tuberculosis by neutrophils: A nonoxidative process
105. Interferon-c-receptor deficiency in an infant with fatal Bacille CalmetteGuerin infection
106. Interleukin-1 signaling is essential for host defense during murine pulmonary tuberculosis
107. Elevated chemokine concentrations in sera of human immunodeficiency virus (HIV)-seropositive and HIV-seronegative patients with tuberculosis: A possible role for mycobacterial lipoarabinomannan
108. Tumor necrosis factor and interleukin-1 inhibitors as markers of disease activity of tuberculosis
109. Serum concentrations of lipopolysaccharide activity-modulating proteins during tuberculosis
110. IL-15, an immunomodulator of T cell responses in intracellular infection
111. Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice
112. Selective expression of monocyte chemotactic and activating factor/monocyte chemoattractant protein 1 in human blood monocytes by Mycobacterium tuberculosis
113. Gamma/delta and other unconventional T lymphocytes: What do they see and what do they do?
114. Infection by Mycobacterium tuberculosis promotes human alveolar macrophage apoptosis
115. Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent
116. Characterization of interleukin-15 (IL-15) and the IL-15 receptor complex
117. The inducing role of tumor necrosis factor in the development of bactericidal granulomas during BCG infection
118. The possible role of interleukin (IL)-12 and interferon-gamma-inducing factor/IL-18 in protection against experimental Mycobacterium leprae infection in mice
119. Elevated chemokine levels in bronchoalveolar lavage fluid of tuberculosis patients
120. Protective role of gamma/delta T cells and alpha/beta T cells in tuberculosis
121. Lethal tuberculosis in interleukin-6-deficient mutant mice
122. Interleukin-12 secretion by Mycobacterium tuberculosis-infected macrophages
123. Cytokine gene expression profile of circulating CD4+ T cells in active pulmonary tuberculosis
124. Increased release of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha by bronchoalveolar cells lavaged from involved sites in pulmonary tuberculosis
125. Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells
126. Absence of a prominent Th2 cytokine response in human tuberculosis
127. Mutations in the human mannose-binding protein gene: Frequencies in several population groups
128. Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice
129. Type 1 and type 2 cytokine dysregulation in human infectious, neoplastic, and inflammatory diseases
130. Transgene-induced production of IL-4 alters the development and collagen expression of T helper cell 1-type pulmonary granulomas
131. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection
132. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors
133. Human toll-like receptors mediate cellular activation by Mycobacterium tuberculosis
134. A human homologue of the Drosophila Toll protein signals activation of adaptive immunity
135. Identification of a heparin-binding hemagglutinin present in mycobacteria
136. Interferon-gamma-inducing factor enhances T helper 1 cytokine production by stimulated human T cells: Synergism with interleukin-12 for interferon-gamma production
137. Mycobacterium-mediated chemokine expression in pleural mesothelial cells: Role of C-C chemokines in tuberculous pleurisy
138. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: Possible role for limiting pathology
139. Apoptosis, but not necrosis, of infected monocytes is coupled with killing of intracellular bacillus Calmette-Guerin
140. CD1b-mediated T cell recognition of a glycolipid antigen generated from mycobacterial lipid and host carbohydrate during infection
141. CD1c-mediated T-cell recognition of isoprenoid glycolipids in Mycobacterium tuberculosis infection
142. Two types of murine helper T cell clone. 1. Definition according to profiles of lymphokine activities and secreted proteins
143. Two types of mouse helper T cell clones: Implications for immune regulation
144. T cell-derived IL-10 antagonizes macrophage function in mycobacterial infection
145. Increased antimycobacterial immunity in interleukin-10-deficient mice
146. Increased expression of Fas ligand on Mycobacterium tuberculosis infected macrophages: A potential novel mechanism of immune evasion by Mycobacterium tuberculosis?
147. The effect of phenolic glycolipid-I from Mycobacterium leprae on the antimicrobial activity of human macrophages
148. Interleukin-18 induces production of proinflammatory cytokines in mice: No intermediate role for the cytokines of the tumor necrosis factor family and interleukin-1beta
149. Mannose-binding lectin binds to a range of clinically relevant microorganisms and promotes complement deposition
150. A mutation in the interferon-c-receptor gene and susceptibility to mycobacterial infection
151. Inducible nitric oxide synthase in pulmonary alveolar macrophages from patients with tuberculosis
152. Mannosylated lipoarabinomannans inhibit IL-12 production by human dendritic cells: Evidence for a negative signal delivered through the mannose receptor
153. Mice incapable of making IL-4 or IL-10 display normal resistance to infection with Mycobacterium tuberculosis
154. Vaccinated mice remain more susceptible to Mycobacterium tuberculosis infection initiated via the respiratory route than via the intravenous route
155. Consequence of Nramp1 deletion to Mycobacterium tuberculosis infection in mice
156. Toll-like receptor 2-dependent inhibition of macrophage class II MHC expression and antigen processing by 19-kDa lipoprotein of Mycobacterium tuberculosis
157. Mechanism of nitric oxide-dependent killing of Mycobacterium bovis BCG in human alveolar macrophages
158. Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis
159. Increase in tumor necrosis factor alpha- and interleukin-6-secreting cells in peripheral blood mononuclear cells from subjects infected with Mycobacterium tuberculosis
160. Regulation of interferon-gamma production by IL-12 and IL-18
161. Signal transduction pathways activated by the IL-1 receptor family: Ancient signaling machinery in mammals, insects, and plants
162. Novel p19 protein engages IL-12p40 to form a cytokine, IL-23, with biological activities similar as well as distinct from IL-12
163. Cytokine/chemokine cascades in immunity to tuberculosis
164. Interaction of Mycobacterium tuberculosis-induced transforming growth factor β1 and interleukin-10
165. Novel human immunodeficiencies reveal the essential role of type-1 cytokines in immunity to intracellular bacteria
166. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between toll-like receptors
167. Inhibition of macrophage priming by sulfatide from Mycobacterium tuberculosis
168. Sequestration from immune CD4+ T cells of mycobacteria growing in human macrophages
169. Surfactant protein A suppresses reactive nitrogen intermediates by alveolar macrophages in response to Mycobacterium tuberculosis
170. Chemokine receptor 2 serves an early and essential role in resistance to Mycobacterium tuberculosis
171. Apoptosis of human monocytes/macrophages in Mycobacterium tuberculosis infection
172. - T lymphocytes to a microbial antigen
173. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
174. Inhibition of cell-mediated immunity by IL4 and IL10
175. Interleukin-18 (IFN-γ-inducing factor) induces IL-8 and IL-1β via TNFα production from non-CD14+ human blood mononuclear cells
176. Changes in gene expression in macrophages infected with Mycobacterium tuberculosis: A combined transcriptomic and proteomic approach
177. HLA class I profile in Asian Indian patients with pulmonary tuberculosis
178. Associations of HLA-DRB1, DQB1 and DPB1 alleles with pulmonary tuberculosis in south India
179. Secreted lymphotoxin-alpha is essential for the control of an intracellular bacterial infection
180. Macrophage activation: Lipoarabinomannan from avirulent and virulent strains of Mycobacterium tuberculosis differentially induces the early genes c-fos, KC, JE, and tumor necrosis factor-alpha
181. 3 induces nitric oxide synthase and suppresses growth of Mycobacterium tuberculosis in a human macrophage-like cell line
182. +2-dependent cell signaling
183. Vitamin D3, gamma interferon, and control of proliferation of Mycobacterium tuberculosis by human monocytes
184. CD1-restricted microbial lipid antigen-specific recognition found in the CD8+ alpha beta T cell pool
185. Structure and biology of proteoglycans
186. Mycobacterium avium- and Mycobacterium tuberculosis-containing vacuoles are dynamic, fusion-competent vesicles that are accessible to glycosphingolipids from the host cell plasmalemma
187. Chemokines induced by infection of mononuclear phagocytes with mycobacteria and present in lung alveoli during active pulmonary tuberculosis
188. Macrophage-T cell interaction in experimental mycobacterial infection. Selective regulation of co-stimulatory molecules on Mycobacterium-infected macrophages and its implication in the suppression of cell-mediated immune response
189. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: Differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production
190. Immune responsiveness and lymphokine production in patients with tuberculosis and healthy controls
191. Interleukin-6 induces early gamma interferon production in the infected lung but is not required for generation of specific immunity to Mycobacterium tuberculosis infection
192. Cytokine gene activation and modified responsiveness to interleukin-2 in the blood of tuberculosis patients
193. Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF
194. Macrophage phagocytosis of virulent but not attenuated strains of Mycobacterium tuberculosis is mediated by mannose receptors in addition to complement receptors
195. Phagocytosis of Mycobacterium tuberculosis is mediated by human monocyte complement receptors and complement component C3
196. Differences in mannose receptor-mediated uptake of lipoarabinomannan from virulent and attenuated strains of Mycobacterium tuberculosis by human macropbages
197. A macrophage invasion mechanism of pathogenic mycobacteria
198. Type 2 cytokine gene activation and its relationship to extent of disease in patients with tuberculosis
199. Association of functional mutant homozygotes of the mannose binding protein gene with susceptibility to pulmonary tuberculosis in India
200. Corynebacterium parvum- and Mycobacterium bovis bacillus Calmette-Guerin-induced granuloma formation is inhibited in TNF receptor I (TNF-RI) knockout mice and by treatment with soluble TNF-RI
201. Regulation of IL-10 secretion after phagocytosis of Mycobacterium tuberculosis by human monocytic cells
202. Bidirectional effects of cytokines on the growth of Mycobacterium avium within human monocytes
203. A major susceptibility locus for leprosy in India maps to chromosome 10p13
204. CD1-restricted T cell recognition of microbial lipoglycan antigens
205. Evidence for human CD4+ T cells in the CD1-restricted repertoire: Derivation of mycobacteria-reactive T cells from leprosy lesions
206. IL-12 regulates T helper type 1 cytokine responses in human infectious disease
207. Relative contributions of distinct MHC class I-dependent cell populations in protection to tuberculosis infection in mice
208. An epidemic of tuberculosis with a high rate of tuberculin anergy among a population previously unexposed to tuberculosis, the Yanomami Indians of the Brazilian Amazon
209. Transforming growth factor-beta: Biological function and chemical structure
210. Racial differences in susceptibility to infection by Mycobacterium tuberculosis
211. An antimicrobial activity of cytolytic T cells mediated by granulysin
212. Differential effects of cytolytic T cell subsets on intracellular infection
213. T cell mediated immunity to Mycobacterium tuberculosis
214. Lack of acidification in Mycobacterium phagosomes produced by exclusion of the vesicular proton-ATPase
215. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice
216. IL-4 is required for defense against mycobacterial infection
217. Th1/Th2 profiles in tuberculosis, based on the proliferation and cytokine response of blood lymphocytes to mycobacterial antigens
218. IFN-gamma and IL-12 are increased in active compared with inactive tuberculosis
219. Production of tumor necrosis factor alpha by monocytes from patients with pulmonary tuberculosis
220. Natural and synthetic non-peptide antigens recognized by human gamma delta T cells
221. Induction of direct antimicrobial activity through mammalian Toll-like receptors
222. Reference deleted
223. Bacillus Calmette-Guerin mycobacteria stimulate human blood dendritic cells
224. The role of TGF beta in the pathogenesis of human tuberculosis
225. Enhanced production of TGF-beta by blood monocytes from patients with active tuberculosis and presence of TGF-beta in tuberculous granulomatous lung lesions
226. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis
227. Interleukin-12: A proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity
228. Tumor necrosis factor alpha is a determinant of pathogenesis and disease progression in mycobacterial infection in the central nervous system
229. The lectin pathway of complement activation
230. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens
231. Toll-like receptor-2 mediates mycobacteria-induced proinflammatory signaling in macrophages
232. Expression of tumor necrosis factor in vitro by human mononuclear phagocytes stimulated with whole Mycobacterium bovis BCG and mycobacterial antigens
233. Increased production of interleukin 4 by CD4+ and CD8+ T cells from patients with tuberculosis is related to the presence of pulmonary cavities
234. Disease-specific ex vivo stimulation of whole blood for cytokine production: Applications in the study of tuberculosis
235. Modulation of LPS-, PHA- and M. tuberculosis-mediated cytokine production by pentoxifylline and thalidomide
236. IL-6 produced by macrophages infected with Mycobacterium species suppresses T cell responses
237. Production of interleukin-18 in human tuberculosis
238. Exogenous reinfection as a cause of recurrent tuberculosis after curative treatment
239. Regulation of toll-like receptors in human monocytes and dendritic cells
240. Lack of both types 1 and 2 cytokines, tissue inflammatory responses, and immune protection during pulmonary infection by Mycobacterium bovis bacille Calmette-Guerin in IL-12-deficient mice
241. Macrophages are a significant source of type 1 cytokines during mycobacterial infection
242. Regulation of toll-like receptor 2 expression by macrophages following mycobacterium avium infection
243. SP-A enhances uptake of bacillus Calmette-Guerin by macrophages through a specific SP-A receptor
244. Pulmonary epithelial cells are a source of IL-8 in the response to Mycobacterium tuberculosis: Essential role of IL-1 from infected monocytes in a NF-kappa B-dependent network
245. The antigen 85 complex: A major secretion product of Mycobacterium tuberculosis
246. Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: A case-control study
247. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1β on tuberculosis
248. Chronic granulomatous disease. Report on a national registry of 368 patients
249. Protective role of interleukin-1 in mycobacterial infection in IL-1 alpha/beta double-knockout mice
250. Cutting edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2
251. Soluble CD14(1-152) confers responsiveness to both lipoarabinomannan and lipopolysaccharide in a novel HL-60 cell bioassay
252. A coat of many complements
253. Interleukin 12 at the site of disease in tuberculosis
254. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis
255. Enhanced interleukin-8 release and gene expression in macrophages after exposure to Mycobacterium tuberculosis and its.components
256. Mechanisms of stimulation of interleukin-1 beta and tumor necrosis factoralpha by Mycobacterium tuberculosis components
257. Selective receptor blockade during phagocytosis does not alter the survival and growth of Mycobacterium tuberculosis in human macrophages
258. Chemokines: A new classification system and their role in immunity
259. Role of iron in Nramp1-mediated inhibition of mycobacterial growth